This application proposes the establishment of a single Center for AIDS Research (CFAR) located at Harvard Medical School (HMS), called the Harvard Medical School Center for AIDS Research. The HMS CFAR is the product of the long-standing commitment of these institutions to AIDS research, education, and patient care, and builds on the platform of the overwhelming success of the two existing Centers for AIDS Research at DFCI and Partners/MGH. The mission of the Harvard Medical School Center for AIDS Research (HMS CFAR) is to expand, promote, and facilitate collaborative, multidisciplinary activities in AIDS research among CFAR members. The CFAR, with its focus on NIH-sponsored AIDS investigators and their colleagues as members, builds collaborations and provides infrastructure support to coordinate and address emerging research opportunities in basic, clinical, behavioral, and translational AIDS activities. The HMS CFAR members and Core resources will focus on five Scientific Programs: International, Epidemioiogy and Outcomes Research, Pathogenesis, Therapeutics, and Vaccines. These five programs were identified through our strategic planning process and reflect those areas in which Harvard Medical School investigators will expand collaborations to identify and address significant scientific questions in AIDS. This CFAR award will support the integration and continuation of six scientific Core facilities: Clinical, Molecular Virology/Biology, Immunology, Biostatistics, Bioinformatics and Technology, and Small Animal Containment. Additionally, the Administrative Core will provide strategic planning oversight and administrative support to the CFAR. The Developmental Core will support innovative pilot projects related to the goals of the scientific programs and provide funding for recruitment and junior faculty mentorship.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI060354-04
Application #
7274193
Study Section
Special Emphasis Panel (ZAI1-AR-A (J3))
Program Officer
Namkung, Ann S
Project Start
2004-07-01
Project End
2009-06-30
Budget Start
2007-07-01
Budget End
2008-06-30
Support Year
4
Fiscal Year
2007
Total Cost
$3,191,306
Indirect Cost
Name
Harvard University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
047006379
City
Boston
State
MA
Country
United States
Zip Code
02115
Dale, Sannisha K; Safren, Steven A (2018) Striving Towards Empowerment and Medication Adherence (STEP-AD): A Tailored Cognitive Behavioral Treatment Approach for Black Women Living With HIV. Cogn Behav Pract 25:361-376
Addison, Daniel; Lawler, Patrick R; Emami, Hamed et al. (2018) Incidental Statin Use and the Risk of Stroke or Transient Ischemic Attack after Radiotherapy for Head and Neck Cancer. J Stroke 20:71-79
Ojikutu, B O; Nnaji, C; Sithole-Berk, J et al. (2018) African born women living with HIV in the United States: unmet needs and opportunities for intervention. AIDS Care 30:1542-1550
Ojikutu, Bisola O; Bogart, Laura M; Higgins-Biddle, Molly et al. (2018) Facilitators and Barriers to Pre-Exposure Prophylaxis (PrEP) Use Among Black Individuals in the United States: Results from the National Survey on HIV in the Black Community (NSHBC). AIDS Behav 22:3576-3587
Martin-Gayo, Enrique; Cole, Michael B; Kolb, Kellie E et al. (2018) A Reproducibility-Based Computational Framework Identifies an Inducible, Enhanced Antiviral State in Dendritic Cells from HIV-1 Elite Controllers. Genome Biol 19:10
Murray, Eleanor J; Robins, James M; Seage 3rd, George R et al. (2018) Using Observational Data to Calibrate Simulation Models. Med Decis Making 38:212-224
Achuthan, Vasudevan; Perreira, Jill M; Sowd, Gregory A et al. (2018) Capsid-CPSF6 Interaction Licenses Nuclear HIV-1 Trafficking to Sites of Viral DNA Integration. Cell Host Microbe 24:392-404.e8
Biello, Katie B; Mimiaga, Matthew J; Santostefano, Christopher M et al. (2018) MSM at Highest Risk for HIV Acquisition Express Greatest Interest and Preference for Injectable Antiretroviral PrEP Compared to Daily, Oral Medication. AIDS Behav 22:1158-1164
Trifonova, Radiana T; Barteneva, Natasha S (2018) Quantitation of IRF3 Nuclear Translocation in Heterogeneous Cellular Populations from Cervical Tissue Using Imaging Flow Cytometry. Methods Mol Biol 1745:125-153
Malone, Jowanna; Syvertsen, Jennifer L; Johnson, Blake E et al. (2018) Negotiating sexual safety in the era of biomedical HIV prevention: relationship dynamics among male couples using pre-exposure prophylaxis. Cult Health Sex 20:658-672

Showing the most recent 10 out of 1030 publications